COVID-19: Pressure Points: A Catalyst for Collaboration (Global)

As COVID-19 infiltrates every aspect of our daily lives and the world races to respond and to address the pandemic, there is a consistent theme which offers all of us hope. Collaboration. To combat the outbreak, we have seen the emergence of large numbers of companies joining to pool their resources and to cross-share their valuable know-how. Read more

CJEU finds Amazon not liable for direct infringement by unwittingly stocking infringing goods being sold through its website

In a decision published today, the Court of Justice of the European Union has found that Amazon is not liable for unwittingly stocking trade mark infringing goods by third-party sellers (Coty v Amazon C-567/18). The decision means a rejection of the concept of extending liability of platforms, such as Amazon, for direct trade mark infringement … Read more

European Commission strategy for data and AI: Shaping a digital future

On 19 February 2020, the European Commission (the Commission) published three policy papers as part of its strategy to shape Europe's digital future: a white paper on artificial intelligence (AI) (the white paper); a communication on a European strategy for data (the data strategy communication); and a communication on shaping Europe's digital future (the digital future communication).  Read more

What’s next for the UPC project? Our analysis following the German Federal Constitutional Court decision

The Bundesverfassungsgericht (the German Federal Constitutional Court) has released its long-awaited ruling on the complaint against the German ratification of the UPC Agreement. It has found, by 5:3 majority, that the Act by which Germany was to accede to the UPC Agreement is void, because it was not passed with the required parliamentary majority. Without Germany's ratification, the UPC Agreement cannot come into force. What is likely to happen next, and when? Read more

The impact of COVID-19 on competition law in the pharmaceutical sector

The global COVID-19 pandemic has, to an extent, re-directed some of the actions and focus of competition authorities, which are placing increasing scrutiny on several strategic industries to ensure they do not profit from the crisis. Some of these developments, as outlined below, are relevant to the pharmaceutical industry (for information on COVID-19’s more general … Read more

UK will not be a part of the UPC – government confirms

The UK Prime Minister's Office has confirmed (27.02.20) that the UK will not be participating in the UPC system saying: "Participating in a court that applies EU law and bound by the CJEU is inconsistent with our aims of becoming an independent self-governing nation." Read more